UASt regulatory sequences drive expression of RhoL that carries the amino acid replacement G20V. This is expected to result in a constitutively active protein (the mutation is equivalent to the change found in oncogenic Ras, which has been shown to interfere with GTPase activity and maintain the protein in its GTP-bound state).